Has Ellen Neylon received payments from drug or device companies?

Yes. Drug and device makers reported $138,413 in general payments to Ellen Neylon across 787 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ellen Neylon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ellen Neylon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ellen Neylon

Oncology · Las Vegas, NVNPI 1174894554

Payments from drug & device makers

$138,413in general payments, 2019–2025

Across 787 payments — averaging $175.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$87K
Novo Nordisk$35K
Eli Lilly$5K
Abbott$2K
Dexcom, Inc.$1K
Corcept Therapeutics$1K
plus $7K from 41 others

$5,922in research payments, 2019–2025

Across 40 payments — averaging $148.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novo Nordisk AS$3K
Corcept Therapeutics$2K
AbbVie$1K

What the payments were for

Consulting fees$6000%
Speaking & faculty fees$83,30960%
Travel & lodging$32,96124%
Food & beverage$21,37315%
Education$1710%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	318	$86,874
Novo Nordisk	139	$35,103
Eli Lilly	38	$4,846
Abbott	79	$2,061
Dexcom, Inc.	27	$1,243
Corcept Therapeutics	19	$1,062
Amgen(2 entities)	19	$1,043
Bayer	9	$442
AstraZeneca(2 entities)	9	$432
Boehringer Ingelheim	17	$412
Chiesi USA, Inc.	6	$409
Ascendis Pharma Endocrinology Inc	3	$347
Tandem Diabetes Care, Inc.	3	$325
AbbVie	16	$316
Xeris Pharmaceuticals, Inc.	10	$302
Kyowa Kirin, Inc.	7	$286
Sanofi-aventis U.S. LLC	10	$277
Amryt Pharma Holdings Ltd	4	$218
Recordati_rare_diseases_inc.	4	$198
Medtronic	5	$197
Chiasma, Inc.	2	$182
Insulet Corporation	1	$180
Madrigal Pharmaceuticals	2	$155
Nestle Healthcare Nutrition Inc.	2	$151
Averitas Pharma Inc.	3	$140
Incyte Corporation	1	$125
Biohaven Pharmaceutical Holding Company Ltd.	1	$124
Esperion Therapeutics, Inc.	2	$123
Pharmacosmos Therapeutics Inc.	1	$121
Deciphera Pharmaceuticals Inc.	1	$119
BETA Bionics, Inc.	1	$113
Mannkind Corporation	5	$74
Ascensia Diabetes Care US Inc.	3	$50
Soleno Therapeutics, Inc.	2	$48
Radius Health, Inc.	2	$37
Pfizer	2	$33
Almatica Pharma LLC	2	$32
Ionis Pharmaceuticals, Inc.	1	$29
Boston Scientific	2	$28
Amneal Pharmaceuticals LLC	2	$26
Lifescan, Inc.	1	$25
Embecta Corp.	1	$22
Sequel Med Tech, LLC	1	$20
Nevro Corp.	1	$19
Endo Pharmaceuticals Inc.	1	$17
IBSA Pharma Inc.	1	$17
Antares Pharma, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MOUNJARO$61,939
RYBELSUS$30,190
Ozempic$1,817
TEPEZZA$622
DEXCOM G6 TRANSMITTER$607
FREESTYLE LIBRE 3$589
Korlym$461
MYCAPSSA$408
Wegovy$359
iLet Bionic Pancreas$338
Yorvipath$248
t:slim X2 Insulin Pump with Control-IQ$225
RETEVMO$213
MYALEPT$206
Omnipod$180
MINIMED 780G$140
RECORLEV$135
ZENPEP$130
Kerendia$125
RESMETIROM$125

How this compares

Too few oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.

Other oncology in Las Vegas

Jerilyn MendozaLas Vegas$8K
Sheila Marie LopezLas Vegas$2K

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →